Streetbeat News

Price Targets

VTR

Mizuho analyst Vikram Malhorta has reaffirmed a Buy rating on Ventas (NYSE:VTR) and increased the price target from $53 to $56, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:40 pm

AAPL

GOOGL

META

MSFT

NVDA

QQQ

SPY

TSLA

The Market Clubhouse Morning Memo provides daily trade strategies for SPY, QQQ, AAPL, MSFT, TSLA, GOOGL, META, and NVDA, based on a proprietary formula involving price, volume, and options flow. The memo outlines potential support and resistance levels for each asset, suggesting possible price targets for bullish and bearish scenarios. It also advises traders to stay alert to market conditions and adjust strategies accordingly. The memo highlights the importance of premarket activities, economic data releases, and FOMC Minutes for trading decisions. RIPS, a pro trader, curates the memo and offers insights and mentorship through the Market Clubhouse community.

Portfolio Pulse from RIPS

January 03, 2024 | 3:39 pm

PRDO

Barrington Research analyst Alexander Paris has reiterated an Outperform rating on Perdoceo Education (NASDAQ:PRDO) and maintained a price target of $23.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:38 pm

OHI

Mizuho analyst Haendel St. Juste has maintained a Buy rating on Omega Healthcare Investors (NYSE:OHI) but has reduced the price target from $35 to $34.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:37 pm

SBRA

Mizuho analyst Vikram Malhotra has reaffirmed a Buy rating on Sabra Health Care REIT (NASDAQ:SBRA) and increased the price target from $15 to $17, indicating a positive outlook on the company's stock.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:35 pm

FC

Barrington Research analyst Alexander Paris has reiterated an Outperform rating on Franklin Covey (NYSE:FC) and maintained a price target of $55. This reaffirmation of the company's stock performance potential could influence investor sentiment and stock value.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:32 pm

CMPR

Barrington Research analyst Kevin Steinke has maintained an Outperform rating on Cimpress (NASDAQ:CMPR) and increased the price target from $91 to $100.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:30 pm

CBRE

CBRE Group's stock is trading lower following a downgrade by Evercore ISI Group from Outperform to In-Line, despite an increase in the price target from $79 to $96.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:29 pm

SCHW

Charles Schwab's stock (SCHW) is trading lower following a downgrade by Goldman Sachs from 'Buy' to 'Neutral', with a new price target set at $71.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:28 pm

CME

CME Group's stock trades lower following a downgrade from Neutral to Sell by Goldman Sachs, which also set a price target of $195.

Portfolio Pulse from Benzinga Newsdesk

January 03, 2024 | 3:27 pm